Literature DB >> 11464886

Automatic detection and genetic profiling of disseminated neuroblastoma cells.

G Méhes1, A Luegmayr, C M Hattinger, T Lörch, I M Ambros, H Gadner, P F Ambros.   

Abstract

BACKGROUND: Rare tumor cells circulating in the hematopoietic system can escape identification. On the other hand, the nature of these cells, positive for an immunologiCal tumor marker, cannot be determined without any genetic information. PROCEDURE: To overcome these problems a novel computer assisted scanning system for automatic cell search, analysis, and sequential repositioning was developed. This system allows an exact quantitative analysis of rare tumor cells in the bone marrow and peripheral blood by sequential immunological and molecular cytogenetic characterization. RESULTS AND
CONCLUSIONS: In that virtually all tumor cells in a mixing experiment could be recovered unambiguously, we can conclude that the sensitivity of this approach is set by the number of cells available for analysis. Sequential FISH analyses of immunologically positive cells improve both the specificity and the sensitivity of the microscopic minimal residual disease detection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464886     DOI: 10.1002/1096-911X(20010101)36:1<205::AID-MPO1050>3.0.CO;2-G

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  6 in total

1.  Detection of disseminated tumor cells in neuroblastoma: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology.

Authors:  Gabor Méhes; Andrea Luegmayr; Rosa Kornmüller; Ingeborg M Ambros; Ruth Ladenstein; Helmut Gadner; Peter F Ambros
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

2.  Efficiency of manual scanning in recovering rare cellular events identified by fluorescence in situ hybridization: simulation of the detection of fetal cells in maternal blood.

Authors:  Ahmed Emad; Seemi Ayub; Oumar Samassékou; Marie-Chantal Grégoire; Macoura Gadji; Aimé Ntwari; Josée Lamoureux; Francis Hemmings; Triantafyllos Tafas; Michael W Kilpatrick; Kada Krabchi; Régen Drouin
Journal:  J Biomed Biotechnol       Date:  2012-03-08

Review 3.  Review of tumor dormancy therapy using traditional oriental herbal medicine.

Authors:  Jong-Ho Lee; Fan-Pei Koung; Chong-Kwan Cho; Yeon-Weol Lee; Hwa-Seung Yoo
Journal:  J Pharmacopuncture       Date:  2013-03

4.  Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO.

Authors:  Ina Mueller; Karoline Ehlert; Stefanie Endres; Lena Pill; Nikolai Siebert; Silke Kietz; Penelope Brock; Alberto Garaventa; Dominique Valteau-Couanet; Evelyne Janzek; Norbert Hosten; Andreas Zinke; Winfried Barthlen; Emine Varol; Hans Loibner; Ruth Ladenstein; Holger N Lode
Journal:  MAbs       Date:  2017-12-05       Impact factor: 5.857

5.  Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Authors:  K Beiske; S A Burchill; I Y Cheung; E Hiyama; R C Seeger; S L Cohn; A D J Pearson; K K Matthay
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

6.  Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Authors:  Ana P Berbegall; Dominik Bogen; Ulrike Pötschger; Klaus Beiske; Nick Bown; Valérie Combaret; Raffaella Defferrari; Marta Jeison; Katia Mazzocco; Luigi Varesio; Ales Vicha; Shifra Ash; Victoria Castel; Carole Coze; Ruth Ladenstein; Cormac Owens; Vassilios Papadakis; Ellen Ruud; Gabriele Amann; Angela R Sementa; Samuel Navarro; Peter F Ambros; Rosa Noguera; Inge M Ambros
Journal:  Br J Cancer       Date:  2018-05-14       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.